TP53 and cancer: Considering cancer patients receiving external beam radiation therapy exhibit pronounced CH mutations in DDR genes (TP53, CHEK2, PPM1D) along with faster clone growth following cumulative exposure33, it can be postulated that exposure to space IR may alter the fitness landscape of observed CH mutations and warrants further investigation.